Literature DB >> 22038638

Successful bridge to recovery using a microaxial blood pump in a patient with electrical storm and cardiogenic shock.

A Henning1, J Schreieck, R Riessen, M Gawaz, A E May.   

Abstract

A 59-year-old patient with dilated cardiomyopathy and incessant ventricular tachycardia leading to progressive cardiogenic shock is presented. Due to hemodynamic instability, high dose catecholamines were required in addition to the implantation of an intraaortic balloon pump (IABP), which, however, appeared to further augment the frequency and duration of ventricular tachycardias. The implantation of a microaxial blood pump allowed catecholamine administration to be terminated, thereby, ending this vicious circle of catecholamine-driven electrical storm. Within 5 days, the patient was hemodynamically stabilized and kidney and liver function recovered with the support of intensive antiarrhythmic therapy (amiodarone, mexiletine, sotalol). During a 24-month follow-up, the patient had no further ICD shocks and no rehospitalization was required for treatment of congestive heart failure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038638     DOI: 10.1007/s00063-011-0047-0

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  12 in total

1.  Percutaneous right ventricular support during catheter ablation of intra-atrial reentrant tachycardia in an adult with a mustard baffle--a novel use of the Impella device.

Authors:  Steven B Fishberger; Jeremy D Asnes; Nancy L Rollinson; Michael W Cleman
Journal:  J Interv Card Electrophysiol       Date:  2010-04-13       Impact factor: 1.900

2.  Long-term safety and sustained left ventricular recovery: long-term results of percutaneous left ventricular support with Impella LP2.5 in ST-elevation myocardial infarction.

Authors:  Annemarie E Engström; Annemarie Engström; Krischan D Sjauw; Krischan Sjauw; Jan Baan; Maurice Remmelink; Bimmer E P M Claessen; Bimmer Claessen; Wouter J Kikkert; Wouter Kikkert; Loes P C Hoebers; Loes Hoebers; Marije M Vis; Marije Vis; Karel T Koch; Karel Koch; Martijn M Meuwissen; Martijn Meuwissen; Jan G P Tijssen; Jan Tijssen; Robbert J De Winter; Robbert De Winter; Jan J Piek; Jan Piek; José P S Henriques; José Henriques
Journal:  EuroIntervention       Date:  2011-02       Impact factor: 6.534

3.  Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5.

Authors:  José P S Henriques; Maurice Remmelink; Jan Baan; René J van der Schaaf; Marije M Vis; Karel T Koch; Evert W Scholten; Bas A J M de Mol; Jan G P Tijssen; Jan J Piek; Robbert J de Winter
Journal:  Am J Cardiol       Date:  2006-02-13       Impact factor: 2.778

4.  Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure.

Authors:  Michael J Jurmann; Henryk Siniawski; Michael Erb; Thorsten Drews; Roland Hetzer
Journal:  Ann Thorac Surg       Date:  2004-05       Impact factor: 4.330

5.  The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience.

Authors:  M P Siegenthaler; K Brehm; T Strecker; T Hanke; A Nötzold; M Olschewski; M Weyand; H Sievers; F Beyersdorf
Journal:  J Thorac Cardiovasc Surg       Date:  2004-03       Impact factor: 5.209

6.  First successful bridge to recovery with the Impella Recover 100 left ventricular assist device for fulminant acute myocarditis.

Authors:  Tiziano Colombo; Andrea Garatti; Giuseppe Bruschi; Marco Lanfranconi; Claudio Russo; Filippo Milazzo; Emanuele Catena; Maria Frigerio; Ettore Vitali
Journal:  Ital Heart J       Date:  2003-09

7.  Initial experience with the Impella Recover LP 2.5 micro-axial pump in patients undergoing high-risk coronary angioplasty.

Authors:  Sofia Thomopoulou; Athanassios Manginas; Dennis V Cokkinos
Journal:  Hellenic J Cardiol       Date:  2008 Nov-Dec

8.  A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.

Authors:  Simon R Dixon; José P S Henriques; Laura Mauri; Krischan Sjauw; Andrew Civitello; Biswajit Kar; Pranav Loyalka; Frederic S Resnic; Paul Teirstein; Raj Makkar; Igor F Palacios; Michael Collins; Jeffrey Moses; Karim Benali; William W O'Neill
Journal:  JACC Cardiovasc Interv       Date:  2009-02       Impact factor: 11.195

9.  A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

Authors:  Melchior Seyfarth; Dirk Sibbing; Iris Bauer; Georg Fröhlich; Lorenz Bott-Flügel; Robert Byrne; Josef Dirschinger; Adnan Kastrati; Albert Schömig
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

10.  Use of the Impella microaxial blood pump for ablation of hemodynamically unstable ventricular tachycardia.

Authors:  Hussam Abuissa; John Roshan; Bernard Lim; Samuel J Asirvatham
Journal:  J Cardiovasc Electrophysiol       Date:  2009-12-21
View more
  2 in total

Review 1.  Extracorporeal life support for refractory ventricular tachycardia.

Authors:  Sujatha P Bhandary; Nicholas Joseph; James P Hofmann; Theodosios Saranteas; Thomas J Papadimos
Journal:  Ann Transl Med       Date:  2017-02

2.  [Electrical storm in the emergency room: clinical pathways].

Authors:  Anja Schade; Karin Nentwich; Patrick Müller; Joachim Krug; Sebastian Kerber; Thomas Deneke
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.